Updated 2/23/2024: There is a system outage and certain functions, such as scheduling, may not be available today. We will call patients to schedule any upcoming appointments when the system is back online. Our clinics remain open and previously scheduled appointments will continue as planned. We apologize for any inconvenience.

About Us

NCI News

NIH launches research network to evaluate emerging cancer screening technologies

The Cancer Screening Research Network (CSRN) will investigate how to identify cancers earlier, when they may be easier to treat, to ultimately save lives. In late 2024, CSRN plans to launch the Vanguard Study on Multi-Cancer Detection, a pilot study to inform the design of a larger trial of multi-cancer detection tests.

W. Kimryn Rathmell begins work as 17th director of the National Cancer Institute

W. Kimryn Rathmell, M.D., Ph.D., begins her tenure as the 17th director of the National Cancer Institute on December 18, 2023. She comes to NCI from Vanderbilt University Medical Center in Nashville, Tennessee, where she served as the Hugh Jackson Morgan Chair in Medicine, chair of the Department of Medicine, and physician-in-chief.

NCI researchers develop approach that could help supercharge T-cell therapies against solid tumors

New approach may increase the effectiveness of T-cell-based immunotherapy treatments against solid tumors.

NIH immunotherapy pioneer Steven Rosenberg awarded nation’s highest honor for technology and innovation

Steven A. Rosenberg, M.D., Ph.D., has been awarded the National Medal of Technology and Innovation by President Biden. It is the nation's highest honor for technological achievement.

Annual Report to the Nation Part 2: New cancer diagnoses fell abruptly early in the COVID-19 pandemic

New diagnoses of six major cancer types fell in the early part of the pandemic, according to findings from part 2 of the latest Annual Report to the Nation on the Status of Cancer.

NCI unveils comprehensive proteogenomic dataset to help cancer researchers unravel molecular mysteries

NCI’s Clinical Proteomic Tumor Analysis Consortium releases proteogenomic dataset to accelerate cancer discoveries.

NIH study offers insights into how cells reverse their decision to divide

An NCI study shows that cell division can be interrupted by withdrawing growth-promoting signals early on in the process.

Biden-Harris Administration launches initiative to improve cancer outcomes in low-income areas

NCI has awarded $50 million to establish five new centers to study interventions for improving cancer outcomes in persistent poverty communities.

NCI’s ComboMATCH initiative will test new drug combinations guided by tumor biology

ComboMATCH will consist of numerous phase 2 cancer treatment trials that aim to identify promising drug combinations that can advance to larger, more definitive clinical trials.

NCI study outlines opportunities to achieve President Biden’s Cancer Moonshot goal of reducing cancer death rates in the United States

A new study has outlined opportunities for achieving President Biden and First Lady Biden’s Cancer Moonshot goal of reducing the cancer death rate by at least 50% over the next 25 years.